missing translation for 'onlineSavingsMsg'
Learn More

ANAPC2 Monoclonal Antibody (OTI1B11), TrueMAB™, OriGene

Mouse Monoclonal Antibody

Encompass_Preferred

1805.36 DKK - 4034.99 DKK

Specifications

Antigen ANAPC2
Clone OTI1B11
Concentration 0.73 mg/mL
Classification Monoclonal
Conjugate Unconjugated
View More Specs

Products 2
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
17599201
Encompass_Preferred
View Documents
Origene Technologies
TA503406S
30 ÎĽL
1805.36 DKK
30µL
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
17579201
Encompass_Preferred
View Documents
Origene Technologies
TA503406
100 ÎĽL
4034.99 DKK
100µL
View alternative products
Save Up to 
»
Please to purchase this item. Need a web account? Register with us today!
Description

Description

ANAPC2 Monoclonal antibody specifically detects ANAPC2 in Human samples. It is validated for Immunocytochemistry, Western Blot
Specifications

Specifications

ANAPC2
0.73 mg/mL
Unconjugated
Mouse
Human
29882
Primary
ANAPC2
OTI1B11
Monoclonal
Liquid
RUO
Q9UJX6
IgG1
-20° C, Avoid Freeze/Thaw Cycles
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

The Fisher Scientific Encompass Program offers items which are not part of our distribution portfolio. These products typically do not have pictures or detailed descriptions. However, we are committed to improving your shopping experience. Please use the form below to provide feedback related to the content on this product.

Product Title
ANAPC2 Monoclonal Antibody (OTI1B11), TrueMAB™, OriGene

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.